Literature DB >> 19558797

Synthesis and base pairing properties of DNA-RNA heteroduplex containing 5-hydroxyuridine.

Song Cui1, Yong-Hoon Kim, Cheng-Hao Jin, Sang Kook Kim, Man-Hee Rhee, Oh-Shin Kwon, Byung Jo Moon.   

Abstract

5-Hydroxyuridine (5-OHU) is a major lesion of uridine and cytosine produced in RNA by various chemical oxidants. To elucidate its biochemical and biophysical effects on RNA replication, the site-specifically modified oligoribonucleotides containing 5-OHU were synthesized with C5-hydroxy-5'-O-DMTr-2'-TBDMS-uridine phosphoramidite using automated solid phase synthesis. The base-pairing properties of nucleotides opposite 5-OHU in 24 mer oligoribonulcleotides with dNTP were studied using three reverse transcriptases (Super-Script(TM)II-, AMV-, MMLV-RT) in cDNA synthesis. Adenine as well as guanine was incorporated preferentially by all reverse transcriptases. In the UV-melting temperature experiment, the results from the relative stabilities of the base pairs were A : 5-OHU > G : 5-OHU > T : 5-OHU approximately C : 5-OHU. Circular Dichroism (CD) studies showed that DNA-RNA containing 5-OHU heteroduplexes exhibit a similar conformation between the A-type RNA and B-type DNA. These results suggest that 5-OHU from oxidative damage was mainly influenced by adenine mismatch.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19558797     DOI: 10.5483/bmbrep.2009.42.6.373

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  2 in total

1.  Synthesis, base pairing properties and trans-lesion synthesis by reverse transcriptases of oligoribonucleotides containing the oxidatively damaged base 5-hydroxycytidine.

Authors:  Pascal A Küpfer; Christian J Leumann
Journal:  Nucleic Acids Res       Date:  2011-08-18       Impact factor: 16.971

2.  The effect of RNA base lesions on mRNA translation.

Authors:  Alessandro Calabretta; Pascal A Küpfer; Christian J Leumann
Journal:  Nucleic Acids Res       Date:  2015-04-20       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.